• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NVAX

NVAX

Novavax, Inc.

NASDAQHealthcareBiotechnologyUS

USD10.20

-0.01 (-0.10%)

Rating:B-

Company Profile

CEO

John Charles Jacobs

IPO Date

1995-12-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.11

Prev. Close

$10.21

Day Low

$9.94

Day High

$10.31

52W Low

$6.13

52W High

$11.97

Market Cap

$1.68B

Volume

3.07M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

43.5%

Avg Negative

18.9%

Avg Neutral

37.5%

News Feed

Don't Buy Novavax Until Its Covid-19 Vaccine Wins FDA Approval

InvestorPlace·7/30/2021·↓ negative

Why Novavax Stock Is Sliding Today

The Motley Fool·7/27/2021·↓ negative

Novavax Stock May Not Get the Delta Varient Bump Investors Need

InvestorPlace·7/26/2021·↑ positive

3 Red-Hot Stocks That Are Still Dirt Cheap

The Motley Fool·7/25/2021·↑ positive

Do Earnings Reports Matter for Biotech Stocks?

The Motley Fool·7/24/2021·↓ negative

Novavax Is Worth 100% More Given Its Prospects and Value Metrics

InvestorPlace·7/22/2021·↑ positive

Why Novavax Stock Should Continue To Rally

Forbes·7/21/2021·↑ positive

NVAX Stock Increased 12.78%: Why It Happened

Pulse2·7/20/2021·↑ positive

Is Novavax Breaking Out After The Rally?

Benzinga·7/19/2021·↑ positive

Plenty of Upside Potential Looms Ahead of Novavax Stock's Bumpy Road

InvestorPlace·7/19/2021·↑ positive